Direxion Daily Biotech Top 5 Bull 2X ETF (TBXU)
NYSEARCA: TBXU · Real-Time Price · USD
29.57
-0.13 (-0.45%)
At close: Apr 28, 2026, 4:00 PM EDT
29.57
0.00 (0.00%)
After-hours: Apr 28, 2026, 6:30 PM EDT
-0.45% (1D)
| Assets | $3.02M |
| Expense Ratio | 0.98% |
| PE Ratio | n/a |
| Shares Out | 100,001 |
| Dividend (ttm) | $0.51 |
| Dividend Yield | 1.73% |
| Ex-Dividend Date | Mar 24, 2026 |
| Payout Ratio | n/a |
| 1-Year Return | n/a |
| Volume | 1,243 |
| Open | 30.17 |
| Previous Close | 29.71 |
| Day's Range | 29.43 - 30.17 |
| 52-Week Low | 25.71 |
| 52-Week High | 38.89 |
| Beta | n/a |
| Holdings | 10 |
| Inception Date | Oct 1, 2025 |
About TBXU
Fund Home PageThe Direxion Daily Biotech Top 5 Bull 2X ETF (TBXU) is an exchange-traded fund that mostly invests in health care equity. TBXUis passively managed, providing 2x leveraged exposure to an equally-weighted index of the top 5 largest US companies in thebiotechnologysub-industry. TBXU was launched on Oct 1, 2025 and is issued by Direxion.
Asset Class Equity
Category Trading--Leveraged Equity
Region North America
Stock Exchange NYSEARCA
Ticker Symbol TBXU
ETF Provider Direxion
Index Tracked NYSE Biotechnology Top 5 Equal Weight Index
Top 10 Holdings
100.00% of assets| Name | Symbol | Weight |
|---|---|---|
| Dreyfus Govt Cash Man Ins | n/a | 28.20% |
| Goldman Finl Sq Trsry Inst 506 | n/a | 23.71% |
| argenx SE | ARGX | 9.44% |
| Regeneron Pharmaceuticals, Inc. | REGN | 8.60% |
| Amgen Inc. | AMGN | 7.98% |
| Vertex Pharmaceuticals Incorporated | VRTX | 7.77% |
| Gilead Sciences, Inc. | GILD | 7.72% |
| Goldman Sachs Fin Gov 465 Institut | n/a | 5.03% |
| Dx D Biotech T 5 Bull 2x Etf Swap | n/a | 1.08% |
| Dx D Biotech T 5 Bull 2x Etf Swap | n/a | 0.46% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Mar 24, 2026 | $0.09893 | Mar 31, 2026 |
| Dec 23, 2025 | $0.10111 | Dec 31, 2025 |
| Dec 10, 2025 | $0.31143 | Dec 17, 2025 |
News
Trade the Titans: Direxion Debuts New Suite of Leveraged & Inverse ETFs
New York, United States, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Direxion, a leading provider of tactical ETFs, today announced the launch of the Direxion Titans Leveraged & Inverse ETFs, a new suite of fun...
7 months ago - GlobeNewsWire